As with any research and development effort, the DADSS Research Program has published findings throughout the process. In the links below, you can access these articles and research papers, published from 2009 through the present.
Proceedings of the 21st International Technical Conference on the Enhance Safety of Vehicles.
Paper Number 09–0464
Publication Year: 2009
While government regulations play an important role in ensuring vehicle safety, voluntary approaches to the design and implementation of vehicle safety systems are increasing in importance as vehicle manufacturers deploy safety systems well in advance of, and even in the absence of, government regulations requiring them. This paper provides an overview of regulatory and non-regulatory approaches to vehicle technology development and deployment, and will describe a new, innovative public\private partnership underway to develop an in-vehicle alcohol detection system. In response to concerns about limited progress in reducing alcohol-impaired driving in the United States during the last decade, attention is focusing on technological approaches to the problem. One strategy includes efforts to increase the application of current breath alcohol ignition interlocks on the vehicles of Driving While Intoxicated (DWI) offenders. However, in recognition that many alcohol-impaired drivers have not been convicted of DWI, an effort is underway to develop advanced invehicle technologies that could be fitted in vehicles of all drivers to measure driver blood alcohol concentration non-invasively. The Automotive Coalition for Traffic Safety (ACTS, a group funded by vehicle manufacturers) and the National Highway Traffic Safety Administration (NHTSA) have commenced a 5- year cooperative agreement entitled Driver Alcohol Detection System for Safety (DADSS) to explore the feasibility of, and the public policy challenges associated with, widespread use of invehicle alcohol detection technology to prevent alcohol-impaired driving. This paper will outline the approach being taken, and the significant challenges to overcome.
Journal of Biomedical Optics
Publication Year: 2009
Alcohol testing is an expanding area of interest due to the impacts of alcohol abuse that extend well beyond drunk driving. However, existing approaches such as blood and urine assays are hampered in some testing environments by biohazard risks. A noninvasive, in vivo spectroscopic technique offers a promising alternative, as no body fluids are required. The purpose of this work is to report the results of a 36-subject clinical study designed to characterize tissue alcohol measured using near-infrared spectroscopy relative to venous blood, capillary blood, and breath alcohol. Comparison of blood and breath alcohol concentrations demonstrated significant differences in alcohol concentration [root mean square of 9.0 to 13.5 mg∕dL] that were attributable to both assay accuracy and precision as well as alcohol pharmacokinetics. A first-order kinetic model was used to estimate the contribution of alcohol pharmacokinetics to the differences in concentration observed between the blood, breath, and tissue assays. All pair-wise combinations of alcohol assays were investigated, and the fraction of the alcohol concentration variance explained by pharmacokinetics ranged from 41.0% to 83.5%. Accounting for pharmacokinetic concentration differences, the accuracy and precision of the spectroscopic tissue assay were found to be comparable to those of the blood and breath assays.